Psych Capital includes the industry’s leading data and market intelligence platform(s).
Media & Intelligence
PSYCH is a B2B media and intelligence platform for the psychedelic science and healthcare industry. It has quickly become the leading global resource for networking, insights and opportunities – powered by trustworthy data, independent analysis and engaging events that attract the largest B2B audience in the industry.
Awakn Life Sciences is a clinical biotech company researching, developing and delivering evidenced-based psychedelic medicine to treat addiction and other mental health conditions.
Data & Intelligence
Blossom is the leading source for scientific and regulatory data for the psychedelics industry. Blossom is presently collaborating with PSYCH to build the industry’s first SAAS platform.
Are you a founder with a strong track record in science, healthcare or business looking for pre-seed capital or to incubate a company in psychedelic healthcare?